3-[[[6-(4-hydroxyphenyl)-1-(oxan-2-yl)indazol-4-yl]-methylamino]methyl]azetidine-1-carboxylic acid
C24H28N4O4 — CID 175009264
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[[[6-(4-hydroxyphenyl)-1-(oxan-2-yl)indazol-4-yl]-methylamino]methyl]azetidine-1-carboxylic acid
3-[[[6-(4-hydroxyphenyl)-1-(oxan-2-yl)indazol-4-yl]-methylamino]methyl]azetidine-1-carboxylic acid (PubChem CID 175009264) has the molecular formula C24H28N4O4 and a molecular weight of 436.51 g/mol. Its IUPAC name is 3-[[[6-(4-hydroxyphenyl)-1-(oxan-2-yl)indazol-4-yl]-methylamino]methyl]azetidine-1-carboxylic acid.
Molecular Properties
| Compound Name | 3-[[[6-(4-hydroxyphenyl)-1-(oxan-2-yl)indazol-4-yl]-methylamino]methyl]azetidine-1-carboxylic acid |
|---|---|
| PubChem CID | 175009264 |
| Molecular Formula | C24H28N4O4 |
| Molecular Weight | 436.51 g/mol |
| Exact Mass | 436.21 |
| IUPAC Name | 3-[[[6-(4-hydroxyphenyl)-1-(oxan-2-yl)indazol-4-yl]-methylamino]methyl]azetidine-1-carboxylic acid |
| SMILES | CN(CC1CN(C(=O)O)C1)c1cc(-c2ccc(O)cc2)cc2c1cnn2C1CCCCO1 |
| InChI | InChI=1S/C24H28N4O4/c1-26(13-16-14-27(15-16)24(30)31)21-10-18(17-5-7-19(29)8-6-17)11-22-20(21)12-25-28(22)23-4-2-3-9-32-23/h5-8,10-12,16,23,29H,2-4,9,13-15H2,1H3,(H,30,31) |
| InChIKey | RMUXUPSRXRIBGK-UHFFFAOYSA-N |
| XLogP | 4.15 |
| TPSA | 91.06 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 436.51 |
| LogP ≤ 5 | 4.15 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175009264 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.